205-82-3

• 常用中文名：苯并荧蒽
• 常用英文名：Benz[j]fluoranthene
• CAS号：205-82-3
• 分子式：C₂₀H₁₂
• 分子量：252.309
• 相关类别： 分析化学 标准品 化妆品标准品
• 发布时间：2018-05-22 08:00:00
• 更新时间：2024-01-03 13:10:54

• 标准样品。癌症研究。

名称

• 中文名: 苯并[j]荧蒽
• 英文名: Benzo[j]fluoranthene
• 中文别名: 苯并荧蒽
• 英文别名: Benzo<j>fluoroanthen; MFCD03453280; 10,11-Benzfluoranthene; 10,11-Benzofluoranthene; Benzo[j]fluoranthene; 7,8-Benzofluoranthene; Benz[j]fluoranthene; Benzo[l]fluoranthene; BENZO(J)FLUORANTHENE; EINECS 205-910-3; Dibenzo[a,jk]fluorene

物化性质

• 密度: 1.3±0.1 g/cm3
• 沸点: 467.5±12.0 °C at 760 mmHg
• 熔点: 166ºC
• 分子式: C₂₀H₁₂
• 分子量: 252.309
• 闪点: 228.6±13.7 °C
• 精确质量: 252.093903
• LogP: 6.40
• 外观性状: Solid | White
• 蒸汽压: 0.0±0.6 mmHg at 25°C
• 折射率: 1.887
• 储存条件:

  本品应密封保存。

• 稳定性:

  1. 存在于主流烟气中。

  2. IARC致癌性评估：证据充分，引发活性。

• 水溶解性: 微溶：乙醇
• 分子结构:

  1、 摩尔折射率：90.30

  2、 摩尔体积（cm³/mol）：196.0

  3、 等张比容（90.2K）：553.5

  4、 表面张力（dyne/cm）: 63.4

  5、 介电常数：3.51

  6、 偶极距（10^-24cm³）：无可用

  7、 极化率：35.80

• 计算化学:

  1.疏水参数计算参考值（XlogP）:无

  2.氢键供体数量:0

  3.氢键受体数量:0

  4.可旋转化学键数量:0

  5.互变异构体数量:无

  6.拓扑分子极性表面积0

  7.重原子数量:20

  8.表面电荷:0

  9.复杂度:372

  10.同位素原子数量:0

  11.确定原子立构中心数量:0

  12.不确定原子立构中心数量:0

  13.确定化学键立构中心数量:0

  14.不确定化学键立构中心数量:0

  15.共价键单元数量:1

• 更多:

  1.性状：黄色结晶。

  2.密度（g/mL,25/4℃）：未确定

  3.相对蒸汽密度（g/mL,空气=1）：未确定

  4.熔点（ºC）：165

  5.沸点（ºC,常压）：490~495

  6.沸点（ºC,5.2kPa）：未确定

  7.折射率：未确定

  8.闪点（ºC）： 未确定

  9.比旋光度（º）：未确定

  10.自燃点或引燃温度（ºC）：未确定

  11.蒸气压（kPa,25ºC）：未确定

  12.饱和蒸气压（kPa,60ºC）：未确定

  13.燃烧热（KJ/mol）：未确定

  14.临界温度（ºC）：未确定

  15.临界压力（KPa）：未确定

  16.油水（辛醇/水）分配系数的对数值：未确定

  17.爆炸上限（%,V/V）：未确定

  18.爆炸下限（%,V/V）：未确定

  19.溶解性：未确定

MSDS

SECTION 1: Identification of the substance/mixture and of the company/undertaking Product identifiers Product name: Benzo[j]fluoranthene solution REACH No.: A registration number is not available for this substance as the substance or its uses are exempted from registration, the annual tonnage does not require a registration or the registration is envisaged for a later registration deadline. Relevant identified uses of the substance or mixture and uses advised against Identified uses: Laboratory chemicals, Manufacture of substances SECTION 2: Hazards identification Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Skin irritation (Category 2), H315 Eye irritation (Category 2), H319 Carcinogenicity (Category 1B), H350 Specific target organ toxicity - single exposure (Category 3), Respiratory system, Central nervous system, H335, H336 Specific target organ toxicity - repeated exposure, Oral (Category 2), Liver, Blood, H373 Specific target organ toxicity - repeated exposure, Inhalation (Category 2), Central nervous system, H373 Chronic aquatic toxicity (Category 3), H412 For the full text of the H-Statements mentioned in this Section, see Section 16. Classification according to EU Directives 67/548/EEC or 1999/45/EC T ToxicR45 R67, R36/37/38 R52/53 For the full text of the R-phrases mentioned in this Section, see Section 16. Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal wordDanger Hazard statement(s) H315Causes skin irritation. H319Causes serious eye irritation. H335May cause respiratory irritation. H336May cause drowsiness or dizziness. H350May cause cancer. H373May cause damage to organs (Liver, Blood) through prolonged or repeated exposure if swallowed. H373May cause damage to organs (Central nervous system) through prolonged or repeated exposure if inhaled. H412Harmful to aquatic life with long lasting effects. Precautionary statement(s) P201Obtain special instructions before use. P261Avoid breathing vapours. P273Avoid release to the environment. P305 + P351 + P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313IF exposed or concerned: Get medical advice/ attention. Supplemental Hazardnone Statements Restricted to professional users. According to European Directive 67/548/EEC as amended. Hazard symbol(s)T Toxic R-phrase(s) R45May cause cancer. R36/37/38Irritating to eyes, respiratory system and skin. R52/53Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. R67Vapours may cause drowsiness and dizziness. S-phrase(s) S53Avoid exposure - obtain special instructions before use. S26In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S45In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). S61Avoid release to the environment. Refer to special instructions/ Safety data sheets. Restricted to professional users. Other hazards - none SECTION 3: Composition/information on ingredients Mixtures Formula: C20H12 Molecular Weight: 252,31 g/mol Hazardous ingredients according to Regulation (EC) No 1272/2008 ComponentClassificationConcentration Methylene chloride CAS-No.75-09-2Skin Irrit. 2; Eye Irrit. 2; Carc.<= 100 % EC-No.200-838-92; STOT SE 3; STOT RE 2; Index-No.602-004-00-3H315, H319, H335, H336, H351, H373, H373 Benz(j)fluoranthene CAS-No.205-82-3Carc. 1B; Aquatic Acute 1;0,1 - 0,25 % EC-No.205-910-3Aquatic Chronic 1; H350, Index-No.601-035-00-XH410 Hazardous ingredients according to Directive 1999/45/EC ComponentClassificationConcentration Methylene chloride CAS-No.75-09-2Xn, Carc.Cat.3, Xi, R36/37/38 <= 100 % EC-No.200-838-9- R40 - R67 Index-No.602-004-00-3 Benz(j)fluoranthene CAS-No.205-82-3T, N, Carc.Cat.2, R45 -0,1 - 0,25 % EC-No.205-910-3R50/53 Index-No.601-035-00-X For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 SECTION 4: First aid measures Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 Indication of any immediate medical attention and special treatment needed no data available SECTION 5: Firefighting measures Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards arising from the substance or mixture Carbon oxides, Hydrogen chloride gas Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. Further information no data available SECTION 6: Accidental release measures Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. For personal protection see section 8. Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Methods and materials for containment and cleaning up Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed containers for disposal. Reference to other sections For disposal see section 13. SECTION 7: Handling and storage Precautions for safe handling Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.Avoid exposure - obtain special instructions before use. For precautions see section 2.2. Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage. Heat sensitive. Specific end use(s) A part from the uses mentioned in section 1.2 no other specific uses are stipulated SECTION 8: Exposure controls/personal protection Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multi-purpose combination (US) or type AXBEK (EN 14387) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. SECTION 9: Physical and chemical properties Information on basic physical and chemical properties a) AppearanceForm: liquid b) Odourno data available c) Odour Thresholdno data available d) pHno data available e) Melting point/freezingno data available point f) Initial boiling point and 40,0 °C at 1.013,2 hPa boiling range g) Flash pointno data available h) Evapouration rateno data available i) Flammability (solid, gas) no data available j) Upper/lowerno data available flammability or explosive limits k) Vapour pressure470,9 hPa at 20,0 °C l) Vapour densityno data available m) Relative densityno data available n) Water solubilityslightly soluble o) Partition coefficient: n- no data available octanol/water p) Auto-ignitionno data available temperature q) Decompositionno data available temperature r) Viscosityno data available s) Explosive propertiesno data available t) Oxidizing propertiesno data available Other safety information no data available SECTION 10: Stability and reactivity Reactivity no data available Chemical stability Stable under recommended storage conditions. Possibility of hazardous reactions no data available Conditions to avoid no data available Incompatible materials Bases, Alkali metals, Strong acids and strong bases, Strong oxidizing agents, Amines, Vinyl compounds, Aluminum, Magnesium Hazardous decomposition products Other decomposition products - no data available In the event of fire: see section 5 SECTION 11: Toxicological information Information on toxicological effects Acute toxicity Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitisation no data available Germ cell mutagenicity no data available Carcinogenicity IARC:2B - Group 2B: Possibly carcinogenic to humans (Methylene chloride) IARC:2B - Group 2B: Possibly carcinogenic to humans (Benz(j)fluoranthene) Reproductive toxicity no data available Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure Inhalation - May cause damage to organs through prolonged or repeated exposure. - Central nervous system Oral - May cause damage to organs through prolonged or repeated exposure. - Liver, Blood Aspiration hazard no data available Additional Information RTECS: Not available Dichloromethane is metabolized in the body producing carbon monoxide which increases and sustains carboxyhemoglobin levels in the blood, reducing the oxygen-carrying capacity of the blood., Acts as a simple asphyxiant by displacing air., anesthetic effects, Breathing difficulties, Headache, Dizziness, Prolonged or repeated contact with skin may cause:, defatting, Dermatitis, Contact with eyes can cause:, Redness, Blurred vision, Provokes tears. SECTION 12: Ecological information Toxicity no data available Persistence and degradability no data available Bioaccumulative potential no data available Mobility in soil no data available Results of PBT and vPvB assessment PBT/vPvB assessment not available as chemical safety assessment not required/not conducted Other adverse effects Harmful to aquatic life with long lasting effects. SECTION 13: Disposal considerations Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Contaminated packaging Dispose of as unused product. SECTION 14: Transport information UN number ADR/RID: 1593IMDG: 1593IATA: 1593 UN proper shipping name ADR/RID: DICHLOROMETHANE, SOLUTION IMDG: DICHLOROMETHANE, SOLUTION IATA:Dichloromethane, SOLUTION Transport hazard class(es) ADR/RID: 6.1IMDG: 6.1IATA: 6.1 Packaging group ADR/RID: IIIIMDG: IIIIATA: III Environmental hazards ADR/RID: noIMDG Marine pollutant: noIATA: no Special precautions for user no data available SECTION 15 - REGULATORY INFORMATION N/A SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : DF6300000 CHEMICAL NAME : Benzo(j)fluoranthene CAS REGISTRY NUMBER : 205-82-3 BEILSTEIN REFERENCE NO. : 2049099 LAST UPDATED : 199710 DATA ITEMS CITED : 18 MOLECULAR FORMULA : C20-H12 MOLECULAR WEIGHT : 252.32 WISWESSER LINE NOTATION : L D6 C6566 1A TJ HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Implant SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 25 mg/kg TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Tumorigenic - tumors at site of application TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Administration onto the skin SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 312 mg/kg/26W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 11102 ug/kg/15D-I TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Kidney, Ureter, Bladder - Kidney tumors TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Implant SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 5 mg/kg TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Tumorigenic - tumors at site of application MUTATION DATA TEST SYSTEM : Rodent - mouse DOSE/DURATION : 3760 nmol/kg REFERENCE : PAACA3 Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- Volume(issue)/page/year: 25,121,1984 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 3,82,1973 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 32,155,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 32,155,1983 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: Pc,4,1972 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-FRANCE;Carcinogen JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - E0465 No. of Facilities: 142 (estimated) No. of Industries: 3 No. of Occupations: 3 No. of Employees: 2283 (estimated)

安全

• 符号: GHS07, GHS08
• 信号词: Danger
• 危害声明: H315-H319-H335-H336-H350-H373-H412
• 警示性声明: P201-P261-P273-P305 + P351 + P338-P308 + P313
• 靶器官: Blood, Central nervous system, Liver
• 危害码 (欧洲): T: Toxic;N: Dangerous for the environment;
• 风险声明 (欧洲): 45-50/53-63-43-36/37/38-23/24/25
• 安全声明 (欧洲): 45-53-61-60-36/37-24/25-23-26
• 危险品运输编码: UN 3077
• 包装等级: III
• 危险类别: 6.1(b)
• 海关编码: 2902909090

合成路线

海关

海关编码	2902909090
中文概述	2902909090. 其他芳香烃. 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:2.0%. 普通关税:30.0%
申报要素	品名, 成分含量
Summary	2902909090 other aromatic hydrocarbons。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:2.0%。General tariff:30.0%